Diaz points to studies showing that the drugs may interfere with the production and secretion of certain hormonal and metabolic factors, possibly disrupting the structural integrity and barrier function of the skin
[DOI] [PMC free article] [PubMed] [Google Scholar] 78.Ross F.C., Patangia D., Grimaud G., Lavelle A., Dempsey E.M., Ross R.P., Stanton C
A previous retrospective study indicated that NAC use was associated with a reduced risk of progression to ESRD, but this was shown in non-DKD, not in DKD patients [12]
Regulatory status in your country is the first question to answer before any further consideration
however, GLP-1 medications such as semaglutide are FDA-approved for obesity treatment
This is a category separate from the Sleepwell dietary supplement Sleepwell is a multi-ingredient supplement supporting sleep (the EFSA frame), not a reagent containing DSIP